Key statistics
As of last trade, Immuron Ltd (ANW:FRA) traded at 0.014, 27.27% above the 52 week low of 0.011 set on Jan 12, 2026.
52-week range
| Open | 0.014 |
|---|---|
| High | 0.014 |
| Low | 0.014 |
| Bid | 0.014 |
| Offer | 0.031 |
| Previous close | 0.0145 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 326.65m |
| Free float | 324.21m |
| P/E (TTM) | -- |
| Market cap | 10.13m AUD |
| EPS (TTM) | -0.0226 AUD |
Data delayed at least 15 minutes, as of Feb 11 2026 07:07 GMT.
More ▼
Announcements
- Immuron Reports Continued Sales Growth
- Immuron New U.S. Department of Defense Award & Clinical Trial Update
- Immuron IMM-529 IND approved by FDA
- Immuron Announces Clinical Trial Update
- Immuron Q1 FY26 YoY growth
- Immuron Submits IMM-529 IND to FDA
- Immuron Letter to Shareholders – Projects Update
- Immuron partners with InvestorHub
- Immuron - FY25 global sales exceed projection, up 49% on prior year
- Immuron Letter to Shareholders: Projects Update
More ▼
